Literature DB >> 23406268

A comparison between 4 and 6 implants in the maxillary posterior region to support an overdenture; 1-year results from a randomized controlled trial.

Wim Slot1, Gerry M Raghoebar, Arjan Vissink, Henny J A Meijer.   

Abstract

OBJECTIVE: To compare the treatment outcome of 4 vs. 6 bar-connected implants in the posterior region of the maxilla to support an overdenture during a 1-year follow-up period.
MATERIALS AND METHODS: Sixty-six edentulous patients with an insufficient amount of bone volume in the maxilla to place implants were asked to participate in this study. Randomization assigned patients to either 4 or 6 implants. In all patients, a maxillary sinus floor elevation procedure with bone from the iliac crest was performed, and after a 3-month healing period, 4 or 6 dental implants were inserted in the maxillary posterior region in a one-stage procedure. After 3 months of osseointegration, a bar-supported overdenture was constructed. Implant survival, overdenture survival, clinical scores, peri-implant bone height changes and patients' satisfaction were assessed. Study analysis was performed according a non-inferiority design.
RESULTS: All patients completed the one-year follow-up. After a functional period of 1-year, implant survival was 100% in the 4 implants group and 99.5% in the 6 implants group. Overdenture survival was 100% in both groups. Mean clinical scores were very low and did not significantly differ between groups. Mean marginal bone resorption was 0.35 ± 0.31 mm and 0.46 ± 0.34 mm in the 4 and 6 implants group, respectively. Patients' satisfaction improved significantly in both groups, but did not differ between groups.
CONCLUSION: A bar-supported overdenture on 4 implants in the posterior maxillary region is not inferior to an overdenture supported by 6 bar-connected dental implants.
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Keywords:  dental implants; edentulous; healthy ageing; maxilla; overdenture

Mesh:

Substances:

Year:  2013        PMID: 23406268     DOI: 10.1111/clr.12118

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  6 in total

1.  Patient satisfaction and survival of maxillary overdentures supported by four or six splinted implants: a systematic review with meta-analysis.

Authors:  Fabrizio Di Francesco; Emilio A Cafferata; Gennaro De Marco; Estefani B Capcha; Alessandro Lanza; Corina M Cristache; Rolando Vernal
Journal:  BMC Oral Health       Date:  2021-05-08       Impact factor: 2.757

2.  An economic evaluation of maxillary implant overdentures based on six vs. four implants.

Authors:  Stefan Listl; Leonhard Fischer; Nikolaos Nikitas Giannakopoulos
Journal:  BMC Oral Health       Date:  2014-08-18       Impact factor: 2.757

3.  Masticatory ability improves after maxillary implant overdenture treatment: A randomized controlled trial with 1-year follow-up.

Authors:  Geessien C Boven; Caroline M Speksnijder; Henny J A Meijer; Arjan Vissink; Gerry M Raghoebar
Journal:  Clin Implant Dent Relat Res       Date:  2019-02-11       Impact factor: 3.932

4.  Incidence of peri-implant mucositis and peri-implantitis in patients with a maxillary overdenture: A sub-analysis of two prospective studies with a 10-year follow-up period.

Authors:  Pieter Onclin; Wim Slot; Arjan Vissink; Gerry M Raghoebar; Henny J A Meijer
Journal:  Clin Implant Dent Relat Res       Date:  2022-02-08       Impact factor: 4.259

5.  Interventions for replacing missing teeth: attachment systems for implant overdentures in edentulous jaws.

Authors:  Alan Gt Payne; Nabeel Hm Alsabeeha; Momen A Atieh; Marco Esposito; Sunyoung Ma; Marwah Anas El-Wegoud
Journal:  Cochrane Database Syst Rev       Date:  2018-10-11

6.  Systemic Trans- and Postoperative Evaluations of Patients Undergoing Dental Implant Surgery.

Authors:  Marcelo Coelho Goiato; Joel Ferreira Santiago Junior; Eduardo Piza Pellizzer; Amália Moreno; Luiz Marcelo Ribeiro Villa; Stefan Fiuza de Carvalho Dekon; Paulo Sérgio Perri de Carvalho; Daniela Micheline dos Santos
Journal:  Clinics (Sao Paulo)       Date:  2016-03       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.